BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 15283467)

  • 1. Antiproliferative effect of trichostatin A and HC-toxin in T47D human breast cancer cells.
    Joung KE; Kim DK; Sheen YY
    Arch Pharm Res; 2004 Jun; 27(6):640-5. PubMed ID: 15283467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen receptor enhances the antiproliferative effects of trichostatin A and HC-toxin in human breast cancer cells.
    Min KN; Cho MJ; Kim DK; Sheen YY
    Arch Pharm Res; 2004 May; 27(5):554-61. PubMed ID: 15202563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The histone deacetylase inhibitor, Trichostatin A, enhances radiation sensitivity and accumulation of gammaH2A.X.
    Karagiannis TC; Harikrishnan KN; El-Osta A
    Cancer Biol Ther; 2005 Jul; 4(7):787-93. PubMed ID: 16082178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of Interactions between Cisplatin and Two Histone Deacetylase Inhibitors in MCF7, T47D and MDA-MB-231 Human Breast Cancer Cell Lines - An Isobolographic Analysis.
    Wawruszak A; Luszczki JJ; Grabarska A; Gumbarewicz E; Dmoszynska-Graniczka M; Polberg K; Stepulak A
    PLoS One; 2015; 10(11):e0143013. PubMed ID: 26580554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FR901228, a novel histone deacetylase inhibitor, induces cell cycle arrest and subsequent apoptosis in refractory human pancreatic cancer cells.
    Sato N; Ohta T; Kitagawa H; Kayahara M; Ninomiya I; Fushida S; Fujimura T; Nishimura G; Shimizu K; Miwa K
    Int J Oncol; 2004 Mar; 24(3):679-85. PubMed ID: 14767553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depsipeptide (FR901228) inhibits proliferation and induces apoptosis in primary and metastatic human uveal melanoma cell lines.
    Klisovic DD; Katz SE; Effron D; Klisovic MI; Wickham J; Parthun MR; Guimond M; Marcucci G
    Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2390-8. PubMed ID: 12766035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of radiation sensitivity of human squamous carcinoma cells by histone deacetylase inhibitors.
    Zhang Y; Jung M; Dritschilo A; Jung M
    Radiat Res; 2004 Jun; 161(6):667-74. PubMed ID: 15161353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of apoptosis of lung and esophageal cancer cells treated with the combination of histone deacetylase inhibitor (trichostatin A) and protein kinase C inhibitor (calphostin C).
    Maxhimer JB; Reddy RM; Zuo J; Cole GW; Schrump DS; Nguyen DM
    J Thorac Cardiovasc Surg; 2005 Jan; 129(1):53-63. PubMed ID: 15632825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The histone deacetylase inhibitor trichostatin A induces cell cycle arrest and apoptosis in colorectal cancer cells via p53-dependent and -independent pathways.
    Meng J; Zhang HH; Zhou CX; Li C; Zhang F; Mei QB
    Oncol Rep; 2012 Jul; 28(1):384-8. PubMed ID: 22552631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of trichostatin A and paclitaxel on the proliferation and apoptosis of lung adenocarcinoma cells.
    Zhang S; Zhang QC; Jiang SJ
    Chin Med J (Engl); 2013 Jan; 126(1):129-34. PubMed ID: 23286491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of cell death induced by histone deacetylase inhibitors in androgen receptor-positive prostate cancer cells.
    Rokhlin OW; Glover RB; Guseva NV; Taghiyev AF; Kohlgraf KG; Cohen MB
    Mol Cancer Res; 2006 Feb; 4(2):113-23. PubMed ID: 16513842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone deacetylase inhibitor screening identifies HC toxin as the most effective in intrahepatic cholangiocarcinoma cells.
    Zhou W; Chen X; He K; Xiao J; Duan X; Huang R; Xia Z; He J; Zhang J; Xiang G
    Oncol Rep; 2016 May; 35(5):2535-42. PubMed ID: 26935789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Troglitazone inhibits histone deacetylase activity in breast cancer cells.
    Davies GF; Ross AR; Arnason TG; Juurlink BH; Harkness TA
    Cancer Lett; 2010 Feb; 288(2):236-50. PubMed ID: 19699029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of trichostatin A, a histone deacetylase inhibitor, on glioma proliferation in vitro by inducing cell cycle arrest and apoptosis.
    Wetzel M; Premkumar DR; Arnold B; Pollack IF
    J Neurosurg; 2005 Dec; 103(6 Suppl):549-56. PubMed ID: 16383255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of apoptosis by trichostatin A, a histone deacetylase inhibitor, is associated with inhibition of cyclooxygenase-2 activity in human non-small cell lung cancer cells.
    Choi YH
    Int J Oncol; 2005 Aug; 27(2):473-9. PubMed ID: 16010430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term exposure to estrogen enhances chemotherapeutic efficacy potentially through epigenetic mechanism in human breast cancer cells.
    Chang YW; Singh KP
    PLoS One; 2017; 12(3):e0174227. PubMed ID: 28323900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suberoylanilide hydroxamic acid increases anti-cancer effect of tumor necrosis factor-α through up-regulation of TNF receptor 1 in lung cancer cells.
    You BR; Han BR; Park WH
    Oncotarget; 2017 Mar; 8(11):17726-17737. PubMed ID: 28099148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The histone-deacetylase inhibitor Trichostatin A blocks proliferation and triggers apoptotic programs in hepatoma cells.
    Herold C; Ganslmayer M; Ocker M; Hermann M; Geerts A; Hahn EG; Schuppan D
    J Hepatol; 2002 Feb; 36(2):233-40. PubMed ID: 11830335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18β-Glycyrrhetinic acid potentiates apoptotic effect of trichostatin A on human epithelial ovarian carcinoma cell lines.
    Lee CS; Yang JC; Kim YJ; Jang ER; Kim W; Myung SC
    Eur J Pharmacol; 2010 Dec; 649(1-3):354-61. PubMed ID: 20868669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of apoptosis by apicidin, a histone deacetylase inhibitor, via the activation of mitochondria-dependent caspase cascades in human Bcr-Abl-positive leukemia cells.
    Cheong JW; Chong SY; Kim JY; Eom JI; Jeung HK; Maeng HY; Lee ST; Min YH
    Clin Cancer Res; 2003 Oct; 9(13):5018-27. PubMed ID: 14581377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.